ALB and diabetes mellitus: Also, the hybrid protein whose biological activity is independent of the interaction with human serum albumin is a more suitable alternative than liraglutide for the use in the treatment of patients with severe diabetes where the interaction between albumin and this drug peptide is severely impaired.